Research Interests
Generation of novel malignant tumor models to dissect tumor clonal evolution and cancer cell plasticity
Establishment of efficacy readouts to advance rational drug combination design and precision oncology
Discovery of novel biologics and construction of dedicated systems for their preclinical efficacy assessment
Development of PDCX (Patient-derived tumor cell xenograft) models for prognostic stratification and therapeutic evaluation
Research Topics
Non-genetic mechanisms of tumor heterogeneity in tumor dissemination and therapeutic resistance (Cell Death & Disease, 2026)
Generation of novel extranodal lymphoma models and exploration of precision therapeutic strategies (Frontiers in Immunology, 2023; Frontiers in Oncology, 2023)
Establishment of the OtR model and investigation of precision therapeutic strategies (Animal Models and Experimental Medicine, 2026; Advanced Therapeutics, 2025; Frontiers in Pharmacology, 2024)
Identification and preclinical validation of novel synthetic-lethal interactions and synergistic drug combinations (Journal of Biological Chemistry, 2026; iScience, 2024)
Development and efficacy characterization of novel biologics and gene therapies (Journal of Biological Chemistry, 2025)
Associate professor
Supervisor of Master's Candidates
Alma Mater : CEMCS-SIBCB
Discipline:Clinical Laboratory Diagnostics
The Last Update Time : ..